Proliferative vitreoretinopathy (PVR) is the most serious fibrous complication that causes vision loss after intraocular surgery， and there is currently no effective treatment in clinical. Autophagy is an important cell biological mechanism in maintaining the homeostasis of tissues and cells， resisting the process of EMT. However， it is still unclear whether autophagy could resist intraocular fibrosis and prevent PVR progression. In this study， we investigated the expression of mesenchymal biomarkers in autophagy deficiency cells and found these proteins were increased. The mesenchymal protein transcription factor Twist can bind to autophagy related protein p62 and promote the degradation of Twist， which reduced the expression of mesenchymal markers. By constructing an EMT model of retinal pigment epithelial (RPE) cells in vitro， we found that autophagy was activated in the EMT process of RPE cells. Moreover， in autophagy deficient RPE cell line via knockdown autophagy related protein 7 (Atg7)， the expression of epithelial marker claudin-1 was suppressed and the mesenchymal markers were increased， accompanied by an increase in cell migration and contractility. Importantly， RPE epithelial properties can be maintained by promoting autophagy and effectively reversing TFG-β2-induced RPE fibrosis. These observations reveal that autophagy may be an effective way to treat PVR.